Efficacy and safety of adalimumab in Japanese patients with moderately to severely active ulcerative colitis

Efficacy and safety of adalimumab in Japanese patients with moderately to severely active ulcerative colitis

Bibliographic Details
Main Authors: Suzuki, Yasuo, Motoya, Satoshi, Hanai, Hiroyuki, Matsumoto, Takayuki, Hibi, Toshifumi, Robinson, Anne M., Mostafa, Nael M., Chao, Jingdong, Arora, Vipin, Camez, Anne, Thakkar, Roopal B., Watanabe, Mamoru
Format: Online
Language:English
Published: Springer Japan 2013
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3925299/
id pubmed-3925299
recordtype oai_dc
spelling pubmed-39252992014-02-20 Efficacy and safety of adalimumab in Japanese patients with moderately to severely active ulcerative colitis Suzuki, Yasuo Motoya, Satoshi Hanai, Hiroyuki Matsumoto, Takayuki Hibi, Toshifumi Robinson, Anne M. Mostafa, Nael M. Chao, Jingdong Arora, Vipin Camez, Anne Thakkar, Roopal B. Watanabe, Mamoru Original Article—Alimentary Tract Springer Japan 2013-12-24 2014 /pmc/articles/PMC3925299/ /pubmed/24363029 http://dx.doi.org/10.1007/s00535-013-0922-y Text en © The Author(s) 2013 Open AccessThis article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Suzuki, Yasuo
Motoya, Satoshi
Hanai, Hiroyuki
Matsumoto, Takayuki
Hibi, Toshifumi
Robinson, Anne M.
Mostafa, Nael M.
Chao, Jingdong
Arora, Vipin
Camez, Anne
Thakkar, Roopal B.
Watanabe, Mamoru
spellingShingle Suzuki, Yasuo
Motoya, Satoshi
Hanai, Hiroyuki
Matsumoto, Takayuki
Hibi, Toshifumi
Robinson, Anne M.
Mostafa, Nael M.
Chao, Jingdong
Arora, Vipin
Camez, Anne
Thakkar, Roopal B.
Watanabe, Mamoru
Efficacy and safety of adalimumab in Japanese patients with moderately to severely active ulcerative colitis
author_facet Suzuki, Yasuo
Motoya, Satoshi
Hanai, Hiroyuki
Matsumoto, Takayuki
Hibi, Toshifumi
Robinson, Anne M.
Mostafa, Nael M.
Chao, Jingdong
Arora, Vipin
Camez, Anne
Thakkar, Roopal B.
Watanabe, Mamoru
author_sort Suzuki, Yasuo
title Efficacy and safety of adalimumab in Japanese patients with moderately to severely active ulcerative colitis
title_short Efficacy and safety of adalimumab in Japanese patients with moderately to severely active ulcerative colitis
title_full Efficacy and safety of adalimumab in Japanese patients with moderately to severely active ulcerative colitis
title_fullStr Efficacy and safety of adalimumab in Japanese patients with moderately to severely active ulcerative colitis
title_full_unstemmed Efficacy and safety of adalimumab in Japanese patients with moderately to severely active ulcerative colitis
title_sort efficacy and safety of adalimumab in japanese patients with moderately to severely active ulcerative colitis
description
publisher Springer Japan
publishDate 2013
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3925299/
_version_ 1612058722791587840

Similar Items